nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.219	0.266	CbGbCtD
Olmesartan—ABCC2—Sulfasalazine—ankylosing spondylitis	0.193	0.234	CbGbCtD
Olmesartan—SLCO1B3—Methotrexate—ankylosing spondylitis	0.151	0.183	CbGbCtD
Olmesartan—ABCC2—Dexamethasone—ankylosing spondylitis	0.0961	0.117	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0879	0.107	CbGbCtD
Olmesartan—ABCC2—Methotrexate—ankylosing spondylitis	0.0772	0.0937	CbGbCtD
Olmesartan—Tachycardia—Prednisolone—ankylosing spondylitis	0.000327	0.00185	CcSEcCtD
Olmesartan—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000326	0.00185	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000324	0.00183	CcSEcCtD
Olmesartan—Myalgia—Triamcinolone—ankylosing spondylitis	0.000321	0.00182	CcSEcCtD
Olmesartan—Pneumonia—Methotrexate—ankylosing spondylitis	0.000321	0.00182	CcSEcCtD
Olmesartan—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00032	0.00182	CcSEcCtD
Olmesartan—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00032	0.00182	CcSEcCtD
Olmesartan—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000319	0.00181	CcSEcCtD
Olmesartan—Infestation—Methotrexate—ankylosing spondylitis	0.000319	0.00181	CcSEcCtD
Olmesartan—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000319	0.00181	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000318	0.0018	CcSEcCtD
Olmesartan—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000317	0.0018	CcSEcCtD
Olmesartan—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000317	0.0018	CcSEcCtD
Olmesartan—Discomfort—Triamcinolone—ankylosing spondylitis	0.000317	0.0018	CcSEcCtD
Olmesartan—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000317	0.00179	CcSEcCtD
Olmesartan—Renal failure—Methotrexate—ankylosing spondylitis	0.000313	0.00178	CcSEcCtD
Olmesartan—Angioedema—Dexamethasone—ankylosing spondylitis	0.000313	0.00177	CcSEcCtD
Olmesartan—Angioedema—Betamethasone—ankylosing spondylitis	0.000313	0.00177	CcSEcCtD
Olmesartan—Angiopathy—Prednisone—ankylosing spondylitis	0.000311	0.00176	CcSEcCtD
Olmesartan—Malaise—Dexamethasone—ankylosing spondylitis	0.000309	0.00175	CcSEcCtD
Olmesartan—Malaise—Betamethasone—ankylosing spondylitis	0.000309	0.00175	CcSEcCtD
Olmesartan—Oedema—Triamcinolone—ankylosing spondylitis	0.000308	0.00175	CcSEcCtD
Olmesartan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000308	0.00175	CcSEcCtD
Olmesartan—Vertigo—Betamethasone—ankylosing spondylitis	0.000307	0.00174	CcSEcCtD
Olmesartan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000307	0.00174	CcSEcCtD
Olmesartan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000307	0.00174	CcSEcCtD
Olmesartan—Syncope—Dexamethasone—ankylosing spondylitis	0.000307	0.00174	CcSEcCtD
Olmesartan—Syncope—Betamethasone—ankylosing spondylitis	0.000307	0.00174	CcSEcCtD
Olmesartan—Arrhythmia—Prednisone—ankylosing spondylitis	0.000306	0.00173	CcSEcCtD
Olmesartan—Infection—Triamcinolone—ankylosing spondylitis	0.000306	0.00173	CcSEcCtD
Olmesartan—Infection—Methylprednisolone—ankylosing spondylitis	0.000305	0.00173	CcSEcCtD
Olmesartan—Haematuria—Methotrexate—ankylosing spondylitis	0.000304	0.00172	CcSEcCtD
Olmesartan—Shock—Triamcinolone—ankylosing spondylitis	0.000303	0.00172	CcSEcCtD
Olmesartan—Insomnia—Prednisolone—ankylosing spondylitis	0.000303	0.00172	CcSEcCtD
Olmesartan—Alopecia—Prednisone—ankylosing spondylitis	0.000303	0.00172	CcSEcCtD
Olmesartan—Shock—Methylprednisolone—ankylosing spondylitis	0.000302	0.00171	CcSEcCtD
Olmesartan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000301	0.00171	CcSEcCtD
Olmesartan—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000301	0.00171	CcSEcCtD
Olmesartan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000301	0.00171	CcSEcCtD
Olmesartan—Tachycardia—Triamcinolone—ankylosing spondylitis	0.0003	0.0017	CcSEcCtD
Olmesartan—Mental disorder—Prednisone—ankylosing spondylitis	0.0003	0.0017	CcSEcCtD
Olmesartan—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.0003	0.0017	CcSEcCtD
Olmesartan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000298	0.00169	CcSEcCtD
Olmesartan—Malnutrition—Prednisone—ankylosing spondylitis	0.000298	0.00169	CcSEcCtD
Olmesartan—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000298	0.00169	CcSEcCtD
Olmesartan—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000297	0.00169	CcSEcCtD
Olmesartan—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000297	0.00168	CcSEcCtD
Olmesartan—Myalgia—Dexamethasone—ankylosing spondylitis	0.000291	0.00165	CcSEcCtD
Olmesartan—Myalgia—Betamethasone—ankylosing spondylitis	0.000291	0.00165	CcSEcCtD
Olmesartan—Anxiety—Betamethasone—ankylosing spondylitis	0.00029	0.00165	CcSEcCtD
Olmesartan—Anxiety—Dexamethasone—ankylosing spondylitis	0.00029	0.00165	CcSEcCtD
Olmesartan—Discomfort—Dexamethasone—ankylosing spondylitis	0.000288	0.00163	CcSEcCtD
Olmesartan—Discomfort—Betamethasone—ankylosing spondylitis	0.000288	0.00163	CcSEcCtD
Olmesartan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000287	0.00163	CcSEcCtD
Olmesartan—Pain—Prednisolone—ankylosing spondylitis	0.000286	0.00162	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000284	0.00161	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000283	0.0016	CcSEcCtD
Olmesartan—Vision blurred—Prednisone—ankylosing spondylitis	0.000281	0.00159	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00028	0.00159	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00028	0.00159	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00028	0.00159	CcSEcCtD
Olmesartan—Oedema—Betamethasone—ankylosing spondylitis	0.000279	0.00158	CcSEcCtD
Olmesartan—Oedema—Dexamethasone—ankylosing spondylitis	0.000279	0.00158	CcSEcCtD
Olmesartan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000279	0.00158	CcSEcCtD
Olmesartan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000279	0.00158	CcSEcCtD
Olmesartan—Insomnia—Triamcinolone—ankylosing spondylitis	0.000278	0.00158	CcSEcCtD
Olmesartan—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000278	0.00157	CcSEcCtD
Olmesartan—Infection—Dexamethasone—ankylosing spondylitis	0.000277	0.00157	CcSEcCtD
Olmesartan—Infection—Betamethasone—ankylosing spondylitis	0.000277	0.00157	CcSEcCtD
Olmesartan—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000276	0.00157	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000276	0.00156	CcSEcCtD
Olmesartan—Anaemia—Prednisone—ankylosing spondylitis	0.000275	0.00156	CcSEcCtD
Olmesartan—Shock—Betamethasone—ankylosing spondylitis	0.000275	0.00156	CcSEcCtD
Olmesartan—Shock—Dexamethasone—ankylosing spondylitis	0.000275	0.00156	CcSEcCtD
Olmesartan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000274	0.00155	CcSEcCtD
Olmesartan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000274	0.00155	CcSEcCtD
Olmesartan—Agitation—Prednisone—ankylosing spondylitis	0.000274	0.00155	CcSEcCtD
Olmesartan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Olmesartan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Olmesartan—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Olmesartan—Tachycardia—Betamethasone—ankylosing spondylitis	0.000273	0.00155	CcSEcCtD
Olmesartan—Angioedema—Prednisone—ankylosing spondylitis	0.000272	0.00154	CcSEcCtD
Olmesartan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000271	0.00154	CcSEcCtD
Olmesartan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00027	0.00153	CcSEcCtD
Olmesartan—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00027	0.00153	CcSEcCtD
Olmesartan—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00027	0.00153	CcSEcCtD
Olmesartan—Malaise—Prednisone—ankylosing spondylitis	0.000269	0.00152	CcSEcCtD
Olmesartan—Vertigo—Prednisone—ankylosing spondylitis	0.000268	0.00152	CcSEcCtD
Olmesartan—Syncope—Prednisone—ankylosing spondylitis	0.000267	0.00152	CcSEcCtD
Olmesartan—Anorexia—Betamethasone—ankylosing spondylitis	0.000266	0.00151	CcSEcCtD
Olmesartan—Anorexia—Dexamethasone—ankylosing spondylitis	0.000266	0.00151	CcSEcCtD
Olmesartan—Urticaria—Prednisolone—ankylosing spondylitis	0.000266	0.00151	CcSEcCtD
Olmesartan—Fatigue—Triamcinolone—ankylosing spondylitis	0.000265	0.0015	CcSEcCtD
Olmesartan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000265	0.0015	CcSEcCtD
Olmesartan—Pain—Triamcinolone—ankylosing spondylitis	0.000263	0.00149	CcSEcCtD
Olmesartan—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000262	0.00149	CcSEcCtD
Olmesartan—Hypotension—Dexamethasone—ankylosing spondylitis	0.000261	0.00148	CcSEcCtD
Olmesartan—Hypotension—Betamethasone—ankylosing spondylitis	0.000261	0.00148	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—ankylosing spondylitis	0.00026	0.00147	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000258	0.00146	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000254	0.00144	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000254	0.00144	CcSEcCtD
Olmesartan—Arthralgia—Prednisone—ankylosing spondylitis	0.000254	0.00144	CcSEcCtD
Olmesartan—Myalgia—Prednisone—ankylosing spondylitis	0.000254	0.00144	CcSEcCtD
Olmesartan—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000254	0.00144	CcSEcCtD
Olmesartan—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Olmesartan—Anxiety—Prednisone—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Olmesartan—Insomnia—Dexamethasone—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Olmesartan—Insomnia—Betamethasone—ankylosing spondylitis	0.000253	0.00143	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000252	0.00143	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000251	0.00142	CcSEcCtD
Olmesartan—Discomfort—Prednisone—ankylosing spondylitis	0.000251	0.00142	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—ankylosing spondylitis	0.000251	0.00142	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—ankylosing spondylitis	0.000249	0.00141	CcSEcCtD
Olmesartan—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000246	0.00139	CcSEcCtD
Olmesartan—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000246	0.00139	CcSEcCtD
Olmesartan—Urticaria—Triamcinolone—ankylosing spondylitis	0.000245	0.00139	CcSEcCtD
Olmesartan—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000244	0.00138	CcSEcCtD
Olmesartan—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000243	0.00138	CcSEcCtD
Olmesartan—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000243	0.00138	CcSEcCtD
Olmesartan—Oedema—Prednisone—ankylosing spondylitis	0.000243	0.00138	CcSEcCtD
Olmesartan—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000243	0.00138	CcSEcCtD
Olmesartan—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000243	0.00138	CcSEcCtD
Olmesartan—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000243	0.00138	CcSEcCtD
Olmesartan—Infection—Prednisone—ankylosing spondylitis	0.000242	0.00137	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000241	0.00137	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000241	0.00137	CcSEcCtD
Olmesartan—Back pain—Methotrexate—ankylosing spondylitis	0.000241	0.00137	CcSEcCtD
Olmesartan—Fatigue—Dexamethasone—ankylosing spondylitis	0.000241	0.00137	CcSEcCtD
Olmesartan—Fatigue—Betamethasone—ankylosing spondylitis	0.000241	0.00137	CcSEcCtD
Olmesartan—Shock—Prednisone—ankylosing spondylitis	0.000239	0.00136	CcSEcCtD
Olmesartan—Pain—Dexamethasone—ankylosing spondylitis	0.000239	0.00135	CcSEcCtD
Olmesartan—Pain—Betamethasone—ankylosing spondylitis	0.000239	0.00135	CcSEcCtD
Olmesartan—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000239	0.00135	CcSEcCtD
Olmesartan—Tachycardia—Prednisone—ankylosing spondylitis	0.000237	0.00135	CcSEcCtD
Olmesartan—Skin disorder—Prednisone—ankylosing spondylitis	0.000236	0.00134	CcSEcCtD
Olmesartan—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000235	0.00133	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—ankylosing spondylitis	0.000235	0.00133	CcSEcCtD
Olmesartan—Anorexia—Prednisone—ankylosing spondylitis	0.000232	0.00131	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000231	0.00131	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—ankylosing spondylitis	0.00023	0.00131	CcSEcCtD
Olmesartan—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00023	0.0013	CcSEcCtD
Olmesartan—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00023	0.0013	CcSEcCtD
Olmesartan—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000228	0.00129	CcSEcCtD
Olmesartan—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000228	0.00129	CcSEcCtD
Olmesartan—Malaise—Methotrexate—ankylosing spondylitis	0.000225	0.00127	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—ankylosing spondylitis	0.000224	0.00127	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—ankylosing spondylitis	0.000223	0.00126	CcSEcCtD
Olmesartan—Urticaria—Dexamethasone—ankylosing spondylitis	0.000222	0.00126	CcSEcCtD
Olmesartan—Urticaria—Betamethasone—ankylosing spondylitis	0.000222	0.00126	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000222	0.00126	CcSEcCtD
Olmesartan—Dizziness—Prednisolone—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Olmesartan—Asthenia—Triamcinolone—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Olmesartan—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Olmesartan—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Olmesartan—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Olmesartan—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000221	0.00125	CcSEcCtD
Olmesartan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00022	0.00125	CcSEcCtD
Olmesartan—Insomnia—Prednisone—ankylosing spondylitis	0.00022	0.00125	CcSEcCtD
Olmesartan—Pruritus—Triamcinolone—ankylosing spondylitis	0.000218	0.00123	CcSEcCtD
Olmesartan—Cough—Methotrexate—ankylosing spondylitis	0.000217	0.00123	CcSEcCtD
Olmesartan—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000217	0.00123	CcSEcCtD
Olmesartan—Dyspepsia—Prednisone—ankylosing spondylitis	0.000214	0.00121	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—ankylosing spondylitis	0.000212	0.0012	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—ankylosing spondylitis	0.000212	0.0012	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—ankylosing spondylitis	0.000212	0.0012	CcSEcCtD
Olmesartan—Decreased appetite—Prednisone—ankylosing spondylitis	0.000211	0.0012	CcSEcCtD
Olmesartan—Rash—Prednisolone—ankylosing spondylitis	0.000211	0.0012	CcSEcCtD
Olmesartan—Dermatitis—Prednisolone—ankylosing spondylitis	0.000211	0.0012	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000211	0.00119	CcSEcCtD
Olmesartan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00021	0.00119	CcSEcCtD
Olmesartan—Fatigue—Prednisone—ankylosing spondylitis	0.00021	0.00119	CcSEcCtD
Olmesartan—Headache—Prednisolone—ankylosing spondylitis	0.00021	0.00119	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—ankylosing spondylitis	0.000209	0.00119	CcSEcCtD
Olmesartan—Constipation—Prednisone—ankylosing spondylitis	0.000208	0.00118	CcSEcCtD
Olmesartan—Dizziness—Triamcinolone—ankylosing spondylitis	0.000204	0.00115	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000203	0.00115	CcSEcCtD
Olmesartan—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000203	0.00115	CcSEcCtD
Olmesartan—Infection—Methotrexate—ankylosing spondylitis	0.000202	0.00114	CcSEcCtD
Olmesartan—Feeling abnormal—Prednisone—ankylosing spondylitis	0.0002	0.00114	CcSEcCtD
Olmesartan—Asthenia—Betamethasone—ankylosing spondylitis	0.0002	0.00114	CcSEcCtD
Olmesartan—Asthenia—Dexamethasone—ankylosing spondylitis	0.0002	0.00114	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000199	0.00113	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000199	0.00113	CcSEcCtD
Olmesartan—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000199	0.00113	CcSEcCtD
Olmesartan—Nausea—Prednisolone—ankylosing spondylitis	0.000199	0.00113	CcSEcCtD
Olmesartan—Pruritus—Betamethasone—ankylosing spondylitis	0.000198	0.00112	CcSEcCtD
Olmesartan—Pruritus—Dexamethasone—ankylosing spondylitis	0.000198	0.00112	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—ankylosing spondylitis	0.000197	0.00112	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000196	0.00111	CcSEcCtD
Olmesartan—Vomiting—Triamcinolone—ankylosing spondylitis	0.000196	0.00111	CcSEcCtD
Olmesartan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000195	0.00111	CcSEcCtD
Olmesartan—Rash—Triamcinolone—ankylosing spondylitis	0.000194	0.0011	CcSEcCtD
Olmesartan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000194	0.0011	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—ankylosing spondylitis	0.000194	0.0011	CcSEcCtD
Olmesartan—Rash—Methylprednisolone—ankylosing spondylitis	0.000194	0.0011	CcSEcCtD
Olmesartan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000193	0.0011	CcSEcCtD
Olmesartan—Urticaria—Prednisone—ankylosing spondylitis	0.000193	0.0011	CcSEcCtD
Olmesartan—Headache—Triamcinolone—ankylosing spondylitis	0.000193	0.00109	CcSEcCtD
Olmesartan—Headache—Methylprednisolone—ankylosing spondylitis	0.000192	0.00109	CcSEcCtD
Olmesartan—Abdominal pain—Prednisone—ankylosing spondylitis	0.000192	0.00109	CcSEcCtD
Olmesartan—Body temperature increased—Prednisone—ankylosing spondylitis	0.000192	0.00109	CcSEcCtD
Olmesartan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000191	0.00108	CcSEcCtD
Olmesartan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000191	0.00108	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—ankylosing spondylitis	0.00019	0.00108	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000185	0.00105	CcSEcCtD
Olmesartan—Dizziness—Dexamethasone—ankylosing spondylitis	0.000185	0.00105	CcSEcCtD
Olmesartan—Dizziness—Betamethasone—ankylosing spondylitis	0.000185	0.00105	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—ankylosing spondylitis	0.000184	0.00104	CcSEcCtD
Olmesartan—Nausea—Triamcinolone—ankylosing spondylitis	0.000183	0.00104	CcSEcCtD
Olmesartan—Nausea—Methylprednisolone—ankylosing spondylitis	0.000182	0.00103	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000179	0.00101	CcSEcCtD
Olmesartan—Vomiting—Dexamethasone—ankylosing spondylitis	0.000178	0.00101	CcSEcCtD
Olmesartan—Vomiting—Betamethasone—ankylosing spondylitis	0.000178	0.00101	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000177	0.001	CcSEcCtD
Olmesartan—Rash—Betamethasone—ankylosing spondylitis	0.000176	0.000998	CcSEcCtD
Olmesartan—Rash—Dexamethasone—ankylosing spondylitis	0.000176	0.000998	CcSEcCtD
Olmesartan—Dermatitis—Betamethasone—ankylosing spondylitis	0.000176	0.000997	CcSEcCtD
Olmesartan—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000176	0.000997	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000175	0.000995	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—ankylosing spondylitis	0.000175	0.000994	CcSEcCtD
Olmesartan—Headache—Dexamethasone—ankylosing spondylitis	0.000175	0.000992	CcSEcCtD
Olmesartan—Headache—Betamethasone—ankylosing spondylitis	0.000175	0.000992	CcSEcCtD
Olmesartan—Asthenia—Prednisone—ankylosing spondylitis	0.000174	0.000989	CcSEcCtD
Olmesartan—Pain—Methotrexate—ankylosing spondylitis	0.000174	0.000986	CcSEcCtD
Olmesartan—Pruritus—Prednisone—ankylosing spondylitis	0.000172	0.000976	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000167	0.00095	CcSEcCtD
Olmesartan—Diarrhoea—Prednisone—ankylosing spondylitis	0.000166	0.000944	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000166	0.000942	CcSEcCtD
Olmesartan—Nausea—Dexamethasone—ankylosing spondylitis	0.000166	0.000941	CcSEcCtD
Olmesartan—Nausea—Betamethasone—ankylosing spondylitis	0.000166	0.000941	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—ankylosing spondylitis	0.000161	0.000916	CcSEcCtD
Olmesartan—Dizziness—Prednisone—ankylosing spondylitis	0.000161	0.000912	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000161	0.000911	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000161	0.000911	CcSEcCtD
Olmesartan—Vomiting—Prednisone—ankylosing spondylitis	0.000155	0.000877	CcSEcCtD
Olmesartan—Rash—Prednisone—ankylosing spondylitis	0.000153	0.000869	CcSEcCtD
Olmesartan—Dermatitis—Prednisone—ankylosing spondylitis	0.000153	0.000869	CcSEcCtD
Olmesartan—Headache—Prednisone—ankylosing spondylitis	0.000152	0.000864	CcSEcCtD
Olmesartan—Asthenia—Methotrexate—ankylosing spondylitis	0.000146	0.000827	CcSEcCtD
Olmesartan—Nausea—Prednisone—ankylosing spondylitis	0.000144	0.000819	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—ankylosing spondylitis	0.000144	0.000815	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000139	0.000789	CcSEcCtD
Olmesartan—Dizziness—Methotrexate—ankylosing spondylitis	0.000134	0.000762	CcSEcCtD
Olmesartan—Vomiting—Methotrexate—ankylosing spondylitis	0.000129	0.000733	CcSEcCtD
Olmesartan—Rash—Methotrexate—ankylosing spondylitis	0.000128	0.000727	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—ankylosing spondylitis	0.000128	0.000726	CcSEcCtD
Olmesartan—Headache—Methotrexate—ankylosing spondylitis	0.000127	0.000722	CcSEcCtD
Olmesartan—Nausea—Methotrexate—ankylosing spondylitis	0.000121	0.000685	CcSEcCtD
